JASPER THERAPEUTICS INC
JSPRNASDAQTrading Snapshot
- Day Range
- $0.89 – $0.92
- 52-Week Range
- $0.32 – $3.30
- Volume
- $4.44B
- Avg Volume
- $3.24B
- Shares Outstanding
- 28.0M
- Next Earnings
- Sep 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $3M
- Last Q Revenue
- $729,379
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-3.23
- Dividend Yield
- —
Why Investors Own JSPR
- ✓High-growth profile — revenue up -6.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 30% gross margin and 22% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About JASPER THERAPEUTICS INC
A company profile for JASPER THERAPEUTICS INC isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release, Q2 earnings
Friday's session: top gainers and losers
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
The trading volume of these stocks is deviating from the norm in today's session.
The trading volume of these stocks is deviating from the norm in today's session.
The market is filled with gapping stocks in Friday's session.
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic Alternatives
Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are happening.
Jasper Closes Kira Deal, Extends Cash Runway
Jasper Therapeutics (JSPR) acquires Kira Pharma & raises $132M, extending its cash runway into 2028. Shares surge 20%+.